DocMorris AG

    Jurisdiction
    Switzerland
    LEI
    50670038OH136R5Z4663
    ISIN
    CH0042615283 (ROSE.SW)
    Sectors
    1. Healthcare
    2. Medical - Pharmaceuticals

    Scores

    InsiderPie Expert Score
    trending_flat 49 / 100
    Even with peer group:
    49 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Fundamental strength relative to industry (Mohanram G-Value)
    1 / 7

    Profile

    DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €2.15B
    Gross margin
    9.6%
    EBIT
    -€74.77M
    EBIT margin
    -3.5%
    Net income
    -€228.27M
    Net margin
    -10.6%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €1.21B -43.6% -€116.83M -48.8%
    €1.41B +16.4% -€86.78M -25.7%
    €1.63B +15.2% -€48.31M -44.3%

    Dividends

    No dividend payouts

    Analyst ratings

    5 analysts rated this company in the past 90 days. The average target price is €11.29, this is a change of +71.8% compared to the current price.

    Earnings Calls

    Latest earnings call: August 20, 2025

    Add to watchlist

    Notifications